Association of the Pro12Ala and C1431T polymorphism of the PPARγ2 gene and their haplotypes with obesity and type 2 diabetes

Chinese Journal of Medical Genetics

Volumn 25, Issue 4, 2008, Pages 447-451

  Dong, Chun Ping ^a   He, Lan ^a   Li, Jian Ning ^a   Ye, Feng ^a   He, Ming ^a   Wang, Yi ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Haplotype; Obesity; PPAR gene; Single nucleotide polymorphism; Type 2 diabetes

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2;

ARTICLE; BODY MASS; CONTROL GROUP; CONTROLLED STUDY; DIABETIC PATIENT; DIASTOLIC BLOOD PRESSURE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STATISTICAL SIGNIFICANCE;

ALANINE; AMINO ACID SUBSTITUTION; ASIAN CONTINENTAL ANCESTRY GROUP; DIABETES MELLITUS, TYPE 2; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; OBESITY; POLYMORPHISM, GENETIC; PPAR GAMMA; PROLINE; TRIGLYCERIDES;

EID: 50249109563     PISSN: 10039406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Uwerx J. PPAR gamma, the ultimate thrifty gene. Diabetologia, 1999, 42:1033-1049.
2. Yen CJ, Beamer BA, Negri C, et al. Molecular scanning of the human peroxisome proliferator activated receptorγ (hPPARγ) gene in diabetic Caucasians: identification of a Pro12Ala PPARγ2 missense mutation. Biochem Biophys Res Commun, 1997, 241:270-274.
3. Shi YY, He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res, 2005, 5:97-98.
4. Michael S, Hans HR. The peroxisome proliferator-activated receptor-γ2 Pro12Ala polymorphism. Diabetes, 2002, 51:2341-2347.
5. Deeb SS, Fajas L, Nemoto M, et al. A Pro12Ala substitution in PPARγ2 is associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet, 1998, 20:284-287.
6. Wang GY, Li QF, Deng ZZ, et al. The association study between peroxisome proliferator activated receptor γ2 gene polymorphism and type 2 diabetes mellitus. Chin J Diab, 2002, 10:74-76.
7. Li XL, Zhu BZ, Zhang L, et al. Correlation between polymorphism of Pro12Ala and the frist-order relatives of patients with type 2 diabetes mellitus. Acad J Xi'an Jiaotong Univ, 2006, 27:493-495.
8. Fu J, Chi-Shang BS, Lu YD, et al. The Pro-(12) → Ala substitution in PPARγ2 gene may be a protective factor for the development of type 2 diabetes in China Han population. Chin J Diab, 2005, 13:363-365.
9. Altshuler D, Hirschhorn1 JN, Klannemark M, et al. The common PPARγ Pro12Ala polymorphism is associated with dereased risk of type 2 diabetes. Nat Genet, 2000, 26:76-80.
10. Masud S, Ye S. Effect of the peroxisome proliferator activated receptor-gamma gene Pro12Ala variant on body mass index: a meta-analysis. J Med Genet, 2003, 40:773-780.
11. Ahluwalia M, Evans M, Morrisk K, et al. The influence of the Pro12Ala mutation the PPAR gamma receptor gene on metabolic and clin characteristic in treatment native patients with type 2 diabetes. Diab Obes Metab, 2002, 4:376-378.
12. Frederiksen L, Brodbaek K, Fenger M, et al. Studies of the Pro12ala polymorphism of the PPAR gamma gene in the Danish MONICA cohort: homozygosity of the Ala-allele confers a decreased risk of the insulin resistance syndrome. J Clin Endoc Metab, 2002, 87:3989-3992.
13. Douglas J, Erdos M, Watanabe R, et al. The peroxisome proliferator-activated receptor-γ2 Pro12Ala variant association with type 2 diabetes and trait differences. Diabetes, 2001, 50:886-890.
14. Swarbrick M, Chapman ML, McQuillan B, et al. A Pro12Ala polymorphism in the human peroxisome proliferator-activated receptor-γ2 is associated with combined hyperlipidaemia in obesity. Eur J Endocrinol, 2001, 144:277-282.
15. Wang XL, Oosterhof J, Duarte N. Peroxisome proliferators activated receptor γ C1613T polymorphism and coronary artery disease. Cardiovasc Res, 1999, 44:588-594.
16. Meirhaeghe A, Fajas L, Helbecque N, et al. A genetic polymorphism of the peroxisome proliferator-activated receptor γ gene influences plasma leptin levels in obese humans. Hum Mol Genet, 1998, 7:435-440.
17. Zhao YH, Cong XF, Chen X. The relationship of the Pro12Ala gene and obesity. Molec Cardio Chin, 2003, 3:140-143.
18. Doney AS, Fischer B, Cecil JE, et al. Association of the Pro12Ala and C1431T variants of PPARG and their haplotypes with susceptibility to type 2 diabetes. Diabetologia, 2004, 47:555-558.
19. Evans D, de Heer J, Hagemann C, et al. Association between the P12A and C1431T polymorphisms in the peroxisome prolifetator activated receptor γ (PPARγ) gene and type 2 daibetes. Exp Clin Endocrinol Diabetes, 2001, 109:151-154.
20. Doney A, Fischer B, Frew D, et al. Haplotype analysis of the PPARγ Pro12Ala and C1431T variants reveals opposing associations with body weight. BMC Genet, 2002, 3:21-25.
21. Moon MK, Cho YM, Jung HS, et al. Genetic polymorphism in peroxisome proliferators-activated receptor γ are associated with type 2 diabetes mellitus and obesity in the Korean population. Diab Med, 2005, 22:1161-1166.